Sometimes there’s real progress behind the slick pitch.

An AI-championing health-tech company whose name sounds like that of a consumer group has announced a formal partnership with the Big Tech corporation behind the AI-pioneering Watson technology.

Stopping scams before they’re perpetrated, cutting illicit payments and reducing hours spent by staff on such cases are three of the top benefits administrators believe artificial intelligence could deliver to their operations.

A physician working from home during the COVID-19 crisis may offer cybercriminals a tantalizing target. Taking note of the heightened threat, the AMA and AHA have put together guidance to help foil would-be offenders.

In the first quarter of this year, investors injected a cool $3.1 billion into venture funding for digital health. Then came COVID-19. What will those investors do now?

Two radiologists reflect on what went wrong AI-wise with the Boeing 737 MAX, outlining potential parallels between aviation and their specialty. 

Venture capital firm General Catalyst and other investors are sinking $51 million into Columbus, Ohio-based Olive with the aim of growing the AI startup’s capacity for automating administrative processes in healthcare.

The tech sector is abuzz with high hopes in AI’s potential to help the world beat back COVID-19. A veteran writer who’s been on the high-tech beat for years offers a reality check.

Another healthcare company is leveraging AI to address the new coronavirus pandemic and help identify potential patients who could have the virus.

A new AI app hitting the market could predict sickness before a person even appears sick.

Venture capital investment volume and value continued to flow into the AI technology space in 2019, though the number of big deals dropped globally.

Jvion, an AI-enabled prescriptive analytics company, has launched a data analysis project that aims to find patterns in the spread of viruses that cause acute respiratory illness like the new coronavirus, dubbed COVID-19.